Using the Eμ-Myc model of B-cell lymphoma, mice mutated at the putative CHK1 T505 phosphosite (T505A) in the RelA transactivation domain, exhibited reduced survival. This evidence concerns the gene MYC and B-cell non-Hodgkin lymphoma.